đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
The purpose of this study is to evaluate the safety of administering a comb...
Status
Completed
Location
UCLA Center For Vaccine Research
Start Date
2005-12
Trial ID
NCT00133445
Treatments Being Tested
This protocol posting deals with objectives \& outcome measures of the exte...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05
Trial ID
NCT00322335
The purpose of this study is to evaluate safety, to demonstrate lot-to-lot ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-18
Trial ID
NCT01000974
Pre-licensure studies of GSK Biologicals' PEDIARIX vaccine have shown it to...
Status
Completed
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT00146835
Treatments Being Tested
The new formulation administered as a 4th consecutive dose will be compared...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-14
Trial ID
NCT00611559
Treatments Being Tested
This study will evaluate the safety and immune response of the Novartis Men...
Status
Completed
Location
Growing Up Pediatrics
Start Date
2007-03
Trial ID
NCT00474526